Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis requiring surgery

Archives of Otolaryngology - Head and Neck Surgery

Volumn 122, Issue 11, 1996, Pages 1209-1213

  Kingdom, Todd T ^a,d   Lee, Kelvin C ^b   Fitzsimmons, Stacey C ^c   Cropp, Gerd J ^a  

^a Head and Neck Surgery Branch   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CYSTIC FIBROSIS FOUNDATION   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENE MUTATION; GENOTYPE; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; NOSE SURGERY; NUTRITIONAL STATUS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION;

EID: 0029952840     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1996.01890230055011     Document Type: Article

References (24)

1. Stern RC. Cystic fibrosis: recent developments in diagnosis and treatment. Pediatr Rev. 1986;7:276-286.
2. Ramsey B, Richardson MA. Impact of sinusitis in cystic fibrosis. J Allergy Clin Immunol. 1992:90:547-551.
3. Crockett DM, McGill TJ, Healy GB, Friedman EM, Salkeld LJ. Nasal and paranasal sinus surgery in children with cystic fibrosis. Ann Otol Rhinol Laryngol. 1987:96:367-372.
4. Cepero R, Smith RJ, Catlin FI, et al. Cystic fibrosis-an otolaryngologist's perspective. Otolaryngol Head Neck Surg. 1987:97:356-360.
5. Cystic Fibrosis Foundation. Patient Registry 1994 Annual Data Report. Bethesda, Md: Cystic Fibrosis Foundation; August 1995.
6. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989:245: 1066-1073.
7. Wilschanski M, Zielenski J, Markiewicz D, et al. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr. 1995:127:705-710.
8. Kerem B, Rommens JM, Buchanan, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989:245:1073-1080.
9. The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype with cystic fibrosis. N Engl J Med. 1993:329:1308-1313.
10. Kerem E, Corey M, Kerem B, et al. The relationship between genotype and phenotype in cystic fibrosis - analysis ot the most common mutation (Δ-F50S). N Engl J Med. 1990:323:1517-1522.
11. Johansen HK, Mir M, Hoiby N, Koch C. Schwartz M. Severity of cystic fibrosis in patients homozygous and heterozygous for Δ-f508 mutation. Lancet. 1991; 337:631-634.
12. Highsmith WE, Burch LH, Zhou Z, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. NEngUMed. 1994;331:974-980.
13. Dean M, Santis G. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Hum Genet. 1994:93:364-368.
14. Augarten A, Kerem B, Yahav Y, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849+ Wkb mutation. Lancet. 1993; 342:25-26.
15. Stern RC, Boat TF, Wood RE, Matthews LW, Doershuk CF. Treatment and prognosis of nasal polyps in cystic fibrosis. AJDC. 1982;136:1067-1070.
16. Lee AB, Pitcher-Wilmott RW. The clinical and laboratory correlates of nasal polyps in cystic fibrosis. Int J Pediatr Otorhinolaryngol. 1982;4:209-214.
17. Bernstein JM, Cropp GJ. Nasal polyposis and cystic fibrosis. CF Club Abstr. 1986:27:55.
18. Kingdom TT, Lee KG, Cropp GJ. Chronic sinusitis and a negative sweat test in a patient with cystic fibrosis. Am J Rhlnol. 1995:4:225-228.
19. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993; 122:1-9.
20. Najjar MF, Rowland M. Anthropometric reference data and prevalence of over-weight, United States, 1976-80. Vital Health Stat 2.1987; No. 238.
21. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983:127:725-734.
22. SAS Institute Inc. SAS Users' Guide, I: Statistics. Cary, NC: SAS Institute Inc; 1985.
23. Santis G, Osborne L, Knight RA, Hodson ME. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet. 1990:336: 1081-1083.
24. Campbell PW, Phillips JA. The cystic fibrosis gene and relationships to clinical status. Semin Respir Infect. 1992:7:150-157.